For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Liothyronine sodium - Treatment resistant depression
PAD Profile : Liothyronine sodium - Treatment resistant depression Important
Traffic Light Status
Status 1 of 1.
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
Committee Recommendations
The Surrey Heartlands Integrated Care System Area Prescribing Committee agreed that the decision made by APC in March 2016 still stands and a RED traffic light status for Liothyronine (T3) as an option for treatment resistant depression in a niche group of adults whose depression has failed to respond to several antidepressants and is intolerant to lithium augmentation.
Where liothyronine is prescribed for the treatment of depression only, this should be under the care of an NHS consultant psychiatrist.
The most cost-effective formulation should be prescribed at initiation.